Topic
AI Research
Artificial Intelligence continues to be a primary catalyst for global equity performance, with AI-related indices significantly outperforming the S&P 500 and driving a widening valuation gap between US and global markets. This growth has led to unprecedented concentration in hedge fund portfolios, where crowded Tech longs and record-high gross leverage present significant reversal risks, drawing historical parallels to the mid-1990s Netscape cycle. Beyond public equities, AI adoption is fundamentally reshaping private markets, directing capital toward strategic infrastructure like data centers and defense technology as part of a 'new world order.' In the context of a fragmented global economy, emerging markets are gaining traction as essential hubs for AI manufacturing, supporting attractive outlooks for EM equities through 2026. Additionally, institutional investors are increasingly integrating machine learning quantitative screens into their proprietary methodologies to identify high-yield opportunities in structured products. Collectively, these insights underscore AI's role not just as a thematic tailwind, but as a critical component in both investment infrastructure and geopolitical strategy.
4229 reports available
All reports
Page 144 of 175
Andina Model Update Post Q1
Goldman Sachs · May 14, 2026
Daily Financial Markets Monitor
J.P. Morgan · May 14, 2026
International Market Intelligence Morning Briefing
J.P. Morgan · May 14, 2026
Credit Lens Perspective of EUR Investor
Schroders · May 14, 2026
Key Takeaways From Investor Event Digital Science In Focus
Goldman Sachs · May 14, 2026
Oil Tracker: US Gasoline Market Tightening
Goldman Sachs · May 14, 2026
Asia's Three Troubled Balance of Payments
ANZ · May 14, 2026
Global Forecasts
UBS · May 14, 2026
AI Exposure and Growth Outlook
UBS · May 14, 2026
Position for Transformational Innovation for Long Term Gains
UBS · May 14, 2026
Lotes: Material Cost Remains a Near-Term Overhang
Goldman Sachs · May 14, 2026
Funding the AI Melt Up
The Market Ear · May 14, 2026
PeptiDream 1Q Results and Development Progress
Goldman Sachs · May 14, 2026
Shawbrook Group Q1 2026 Trading Update
Goldman Sachs · May 14, 2026
Americas Healthcare Biotechnology 1Q26 EPS Updates
Goldman Sachs · May 14, 2026
Nobody Owns Enough China
The Market Ear · May 14, 2026
The Case for Liquid Alternatives
GMO · May 14, 2026
Americas Retail Sales April Update
Goldman Sachs · May 14, 2026
Merck KGaA Process Solutions De-risked for 2026
Goldman Sachs · May 14, 2026
Higher Inflation Does Not Preclude Lower Yields
UBS · May 14, 2026
Asia FX Talk
MUFG · May 14, 2026
New Zealand Morning Focus
ANZ · May 14, 2026
Tau Data Calls for Further Analysis into Ph3 Start
Goldman Sachs · May 14, 2026
Equity Client Flow Trends Big Tech Inflows During Sector Rally
Bank of America · May 14, 2026